Abstract
AbstractMicrofluidic devices have been widely used for gene analysis, immunoassays, organ-on-chip technology, cell engineering, and disease modeling. Their integration into high throughput screening (HTS) platforms has led to large-scale testing of various biological and chemical agents. This brief review discusses existing microfluidic HTS modalities, including the droplet mode, the perfusion mode, and the array-based platforms in active or passive designs, by exploring their fabrication methods and key design features. The main compartments are discussed, and the future trajectories of microfluidic HTS platforms, particularly in drug screening, are explained in detail. This review aims to serve as a guide for bioengineers and clinicians, offering insights to advance the development of the microfluidic toolboxes utilized in drug screening efforts.
Publisher
Springer Science and Business Media LLC
Reference161 articles.
1. G. Du, Q. Fang, J.M.J. den Toonder, Microfluidics for cell-based high throughput screening platforms—a review. Anal. Chim. Acta 903, 36–50 (2016)
2. G. Wu, S.K. Doberstein, HTS technologies in biopharmaceutical discovery. Drug Discov. Today 11(15–16), 718–724 (2006)
3. J. Hong, J.R. Lukes, Microfluidic systems for high-throughput screening, in Encyclopedia of Microfluidics and Nanofluidics. ed. by D. Li (Springer, Boston, 2008)
4. E. Brouzes et al., Droplet microfluidic technology for single-cell high-throughput screening. Proc. Natl. Acad. Sci. 106(34), 14195–14200 (2009)
5. M. Sesen, T. Alan, A. Neild, Droplet control technologies for microfluidic high throughput screening (μHTS). Lab Chip 17(14), 2372–2394 (2017)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献